Most Profitable ARCA Pharmaceutical Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
(0.08)
 1.00 
(0.08)
2NVO Novo Nordisk AS
83.68 B
 0.07 
 1.90 
 0.12 
3RDY Dr Reddys Laboratories
60.48 B
(0.10)
 1.29 
(0.13)
4JNJ Johnson Johnson
13.33 B
(0.06)
 0.99 
(0.06)
5NVS Novartis AG ADR
8.57 B
 0.09 
 1.00 
 0.09 
6BMY Bristol Myers Squibb
8.04 B
(0.08)
 1.60 
(0.13)
7AZN AstraZeneca PLC ADR
6.9 B
 0.34 
 1.15 
 0.39 
8SNY Sanofi ADR
5.4 B
 0.08 
 1.38 
 0.11 
9LLY Eli Lilly and
5.24 B
 0.04 
 1.80 
 0.07 
10GSK GlaxoSmithKline PLC ADR
4.93 B
 0.17 
 0.97 
 0.17 
11ABBV AbbVie Inc
4.88 B
(0.07)
 1.26 
(0.09)
12ZTS Zoetis Inc
2.34 B
(0.10)
 2.13 
(0.21)
13PFE Pfizer Inc
2.13 B
 0.03 
 1.59 
 0.06 
14RPRX Royalty PharmaPlc
1.13 B
(0.03)
 1.23 
(0.03)
15OGN Organon Co
1.02 B
 0.15 
 2.48 
 0.38 
16ALKS Alkermes Plc
519.16 M
(0.08)
 2.78 
(0.23)
17JAZZ Jazz Pharmaceuticals PLC
414.83 M
(0.10)
 1.73 
(0.18)
18MRK Merck Company
365 M
 0.07 
 1.01 
 0.07 
19VTRS Viatris
54.7 M
(0.04)
 1.75 
(0.08)
20PRGO Perrigo Company PLC
(12.7 M)
(0.01)
 2.92 
(0.02)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.